290331-05-4Relevant articles and documents
Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase
Bergstrom, Carl P.,Sloan, Charles P.,Lau, Wai-Yu,Smith, David W.,Zheng, Ming,Hansel, Steven B.,Polson, Craig T.,Corsa, Jason A.,Barten, Donna M.,Felsenstein, Kevin M.,Roberts, Susan B.
, p. 464 - 468 (2008/12/21)
The synthesis and γ-secretase inhibition data for a series of carbamate-appended N-alkylsulfonamides are described. Carbamate 54 was found to significantly reduce brain Aβ in transgenic mice. 54 was also found to possess markedly improved brain levels in transgenic mice compared to previously disclosed 1 and 2.
Synthesis of biotinylated photoaffinity probes based on arylsulfonamide γ-secretase inhibitors
Fuwa, Haruhiko,Hiromoto, Kenichi,Takahashi, Yasuko,Yokoshima, Satoshi,Kan, Toshiyuki,Fukuyama, Tohru,Iwatsubo, Takeshi,Tomita, Taisuke,Natsugari, Hideaki
, p. 4184 - 4189 (2007/10/03)
Synthesis and biological evaluation of an arylsulfonamide class of γ-secretase inhibitors are described. Design, synthesis, and biological evaluation of multifunctional molecular probes harboring a benzophenone photophore as a cross-linking group and a biotin tag are also reported.
Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
-
Page/Page column 15, (2010/02/14)
The present invention relates to compounds of the Formula: wherein R1 to R6, X, Z and A are as defined. These compounds have activity inhibiting production of Aβ-peptide. The invention also relates to pharmaceutical compositions and
PHENYLSULFONAMIDE DERIVATIVES FOR TREATING ALZHEIMER'S DISEASE
-
Page 28, (2008/06/13)
The invention relates to phenylsulfonamide derivatives, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular Alzheimer's disease.